DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Bauml J, Seiwert TY, Pfister DG. et al.
Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: results from a single-arm, phase ii study.
J Clin Oncol 2017;
35: 1542-1549
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.